Cardiovascular risks post-COVID-19 vaccination: Key findings

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led to greater rates of MASH resolution, an interim analysis of a

At least three phar­ma com­pa­nies have re­quest­ed to pull patents from an FDA data­base af­ter the Fed­er­al Trade Com­mis­sion chal­lenged more than 100 patents it

As part of MedPage Today‘s occasional series on healthcare clinicians running for office, Washington Editor Joyce Frieden spoke with ob/gyn Kristin Lyerly, MD, a Democrat